feed,title,long_url,short_url
SSRN,"Selection of Optimum Formulation of RBD-Based Protein Sub-Unit COVID19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies",https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4055319,
